These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 3837361

  • 1. [Observation on susceptibilities and immune responses of four strains of mice to the infection of a Leishmania donovani Chinese strain].
    Yi TL, Hu XS, Feng RY.
    Sichuan Yi Xue Yuan Xue Bao; 1985 Jun; 16(2):122-6. PubMed ID: 3837361
    [No Abstract] [Full Text] [Related]

  • 2. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
    Bhaumik SK, Naskar K, De T.
    Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
    [Abstract] [Full Text] [Related]

  • 3. Isotype profiles of Leishmania donovani-infected BALB/c mice: preferential stimulation of IgG2a/b by liposome-associated promastigote antigens.
    Afrin F, Ali N.
    J Parasitol; 1998 Aug; 84(4):743-8. PubMed ID: 9714204
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice.
    Mazumdar T, Anam K, Ali N.
    Vaccine; 2004 Mar 12; 22(9-10):1162-71. PubMed ID: 15003644
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immunostimulant activity of Picroliv, the iridoid glycoside fraction of Picrorhiza kurroa, and its protective action against Leishmania donovani infection in hamsters.
    Puri A, Saxena RP, Sumati, Guru PY, Kulshreshtha DK, Saxena KC, Dhawan BN.
    Planta Med; 1992 Dec 12; 58(6):528-32. PubMed ID: 1484891
    [Abstract] [Full Text] [Related]

  • 8. Non PC liposome entrapped promastigote antigens elicit parasite specific CD8+ and CD4+ T-cell immune response and protect hamsters against visceral leishmaniasis.
    Sharma SK, Dube A, Nadeem A, Khan S, Saleem I, Garg R, Mohammad O.
    Vaccine; 2006 Mar 10; 24(11):1800-10. PubMed ID: 16310900
    [Abstract] [Full Text] [Related]

  • 9. Vaccination with Leishmania soluble antigen and immunostimulatory oligodeoxynucleotides induces specific immunity and protection against Leishmania donovani infection.
    Tewary P, Pandya J, Mehta J, Sukumaran B, Madhubala R.
    FEMS Immunol Med Microbiol; 2004 Oct 01; 42(2):241-8. PubMed ID: 15364110
    [Abstract] [Full Text] [Related]

  • 10. Cell-mediated immune response in experimental visceral leishmaniasis. I. Correlation between resistance to Leishmania donovani and lymphokine-generating capacity.
    Murray HW, Masur H, Keithly JS.
    J Immunol; 1982 Jul 01; 129(1):344-50. PubMed ID: 7086136
    [No Abstract] [Full Text] [Related]

  • 11. Cell-mediated immune response in experimental visceral leishmaniasis. II. Oxygen-dependent killing of intracellular Leishmania donovani amastigotes.
    Murray HW.
    J Immunol; 1982 Jul 01; 129(1):351-7. PubMed ID: 6282967
    [No Abstract] [Full Text] [Related]

  • 12. Leishmania donovani: evolution and architecture of the splenic cellular immune response related to control of infection.
    Melby PC, Tabares A, Restrepo BI, Cardona AE, McGuff HS, Teale JM.
    Exp Parasitol; 2001 Sep 01; 99(1):17-25. PubMed ID: 11708830
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Leishmania donovani vs immunity: T-cells sensitized from Leishmania of one donor may modulate their cytokines pattern on re-stimulation with Leishmania from different donor in visceral leishmaniasis.
    Narayan S, Bimal S, Singh SK, Gupta AK, Singh VP, Sinha PK, Das P.
    Exp Parasitol; 2009 Jan 01; 121(1):69-75. PubMed ID: 18948098
    [Abstract] [Full Text] [Related]

  • 16. Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis.
    Oliveira-Freitas E, Casas CP, Borja-Cabrera GP, Santos FN, Nico D, Souza LO, Tinoco LW, da Silva BP, Palatnik M, Parente JP, Palatnik-de-Sousa CB.
    Vaccine; 2006 May 01; 24(18):3909-20. PubMed ID: 16556475
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Relationship between parasite load and immune responses in early stages of Leishmania donovani infection in inbred BALB/c mice.
    Wahinya DN, Mbati PA, Jomo PM, Githure JI.
    East Afr Med J; 1998 Mar 01; 75(3):156-9. PubMed ID: 9640813
    [Abstract] [Full Text] [Related]

  • 19. Serodiagnostic and immunoprophylactic potential of a 78kDa protein of Leishmania donovani of Indian origin.
    Mukherjee M, Bhattacharyya A, Duttagupta S.
    Med Sci Monit; 2002 Apr 01; 8(4):BR117-22. PubMed ID: 11951057
    [Abstract] [Full Text] [Related]

  • 20. Immunization with the DNA-encoding N-terminal domain of proteophosphoglycan of Leishmania donovani generates Th1-type immunoprotective response against experimental visceral leishmaniasis.
    Samant M, Gupta R, Kumari S, Misra P, Khare P, Kushawaha PK, Sahasrabuddhe AA, Dube A.
    J Immunol; 2009 Jul 01; 183(1):470-9. PubMed ID: 19542458
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.